CA1312030C - Methode pour accroitre le titre d'anticorps - Google Patents

Methode pour accroitre le titre d'anticorps

Info

Publication number
CA1312030C
CA1312030C CA000581361A CA581361A CA1312030C CA 1312030 C CA1312030 C CA 1312030C CA 000581361 A CA000581361 A CA 000581361A CA 581361 A CA581361 A CA 581361A CA 1312030 C CA1312030 C CA 1312030C
Authority
CA
Canada
Prior art keywords
cell
growth
culture
accordance
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000581361A
Other languages
English (en)
Inventor
Brian Maiorella
Duane Inlow
William Howarth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Application granted granted Critical
Publication of CA1312030C publication Critical patent/CA1312030C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/50—Soluble polymers, e.g. polyethyleneglycol [PEG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA000581361A 1987-11-18 1988-10-26 Methode pour accroitre le titre d'anticorps Expired - Lifetime CA1312030C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12201587A 1987-11-18 1987-11-18
US122,015 1987-11-18

Publications (1)

Publication Number Publication Date
CA1312030C true CA1312030C (fr) 1992-12-29

Family

ID=22400058

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000581361A Expired - Lifetime CA1312030C (fr) 1987-11-18 1988-10-26 Methode pour accroitre le titre d'anticorps

Country Status (3)

Country Link
AU (1) AU2805989A (fr)
CA (1) CA1312030C (fr)
WO (1) WO1989004867A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5183754A (en) * 1988-10-04 1993-02-02 Mitsui Toatsu Chemicals, Incorporated Method for production of human tissue type plasminogen activator
US5856179A (en) 1994-03-10 1999-01-05 Genentech, Inc. Polypeptide production in animal cell culture
US5705364A (en) * 1995-06-06 1998-01-06 Genentech, Inc. Mammalian cell culture process
US6656466B1 (en) 1995-06-06 2003-12-02 Genetech, Inc. Human tumor necrosis factor—immunoglobulin(TNFR1-IgG1) chimera composition
US5721121A (en) * 1995-06-06 1998-02-24 Genentech, Inc. Mammalian cell culture process for producing a tumor necrosis factor receptor immunoglobulin chimeric protein
AU2004256354B2 (en) 2003-07-15 2011-07-07 Chugai Seiyaku Kabushiki Kaisha IgM production by transformed cells and methods for quantifying said IgM production
WO2005035574A1 (fr) 2003-10-09 2005-04-21 Chugai Seiyaku Kabushiki Kaisha Solution stabilisee a concentration elevee en igm
WO2005035573A1 (fr) 2003-10-09 2005-04-21 Chugai Seiyaku Kabushiki Kaisha Methode de stabilisation de solution proteinique
CN102596995B (zh) 2009-10-26 2015-08-12 弗·哈夫曼-拉罗切有限公司 用于生产糖基化免疫球蛋白的方法
US10961500B1 (en) * 2019-04-23 2021-03-30 Regeneron Pharmaceuticals, Inc. Cell culture medium for eukaryotic cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1206433A (fr) * 1982-08-06 1986-06-24 Channing R. Robertson Production de produits biologiques a l'aide de cellules au repos
US4724206A (en) * 1984-02-13 1988-02-09 Damon Biotech, Inc. Protein production using hypertonic media
GB8516415D0 (en) * 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells

Also Published As

Publication number Publication date
AU2805989A (en) 1989-06-14
WO1989004867A1 (fr) 1989-06-01

Similar Documents

Publication Publication Date Title
US7070960B2 (en) Method of increasing product expression through solute stress
CA1142466A (fr) Lignees cellulaires
CA1315715C (fr) Lignee cellulaire humaine et triomes, anticorps, et transformants derives
US4594325A (en) High fusion frequency fusible lymphoblastoid cell line
CA1312030C (fr) Methode pour accroitre le titre d'anticorps
Kovář et al. Iron compounds at high concentrations enable hybridoma growth in a protein-free medium
Siraganian et al. [2] Methods of enhancing the frequency of antigen-specific hybridomas
US4198479A (en) Replacement of animal serum proteins by human albumin for growth and interferon production by Namalva cells
GB2251249A (en) High density media for mammalian cell culture
JPS5863385A (ja) 免疫系由来の細胞用培地
HU191984B (en) Process for preparing hybridomes and by means thereof antibodies
Shirahata et al. Cell hybridization, hybridomas, and human hybridomas
US4675295A (en) Process for producing subculturable lymphokine-producing human T cell hybridomas
EP0107528B1 (fr) Lignée de cellules plasmacytoides humaines non-secrétoires
US11186858B1 (en) Methods for increasing biosimilarity
JPH03254679A (ja) 新規細胞株
US11254964B1 (en) Cell culture methods for increased cell viability
CA1218947A (fr) Lignees de cellules hybrides humaines
EP0295605B1 (fr) Facteur stimulateur de la production d'anticorps produit par les cellules lymphoblastoides B et procédé pour la production d'anticorps avec ce facteur stimulateur
SU1495374A1 (ru) Штамм культивируемых клеток животных MUS мUSсULUS - продуцент ростстимулирующих факторов гибридом
SU1576562A1 (ru) Способ культивировани лейкоцитов свиньи
RU2008350C1 (ru) Штамм гибридных культивируемых клеток животных mus musculus l., используемый для получения моноклональных антител к jgg человека
SU1631072A1 (ru) Штамм гибридных культивируемых клеток животных MUS мUSсULUS L., используемый дл получени моноклональных антител к гликопротеидному структурному белку вируса бешенства
Di Sabato et al. Production of thymocyte-stimulating factor by murine spleen lymphocytes: Cellular and biochemical mechanisms
JPH0787799B2 (ja) モノクローナル抗体生産増強法

Legal Events

Date Code Title Description
MKLA Lapsed